730 related articles for article (PubMed ID: 26642243)
1. Loss-of-function mutations in TNFAIP3 leading to A20 haploinsufficiency cause an early-onset autoinflammatory disease.
Zhou Q; Wang H; Schwartz DM; Stoffels M; Park YH; Zhang Y; Yang D; Demirkaya E; Takeuchi M; Tsai WL; Lyons JJ; Yu X; Ouyang C; Chen C; Chin DT; Zaal K; Chandrasekharappa SC; Hanson EP; Yu Z; Mullikin JC; Hasni SA; Wertz IE; Ombrello AK; Stone DL; Hoffmann P; Jones A; Barham BK; Leavis HL; van Royen-Kerkof A; Sibley C; Batu ED; Gül A; Siegel RM; Boehm M; Milner JD; Ozen S; Gadina M; Chae J; Laxer RM; Kastner DL; Aksentijevich I
Nat Genet; 2016 Jan; 48(1):67-73. PubMed ID: 26642243
[TBL] [Abstract][Full Text] [Related]
2. Recruitment of A20 by the C-terminal domain of NEMO suppresses NF-κB activation and autoinflammatory disease.
Zilberman-Rudenko J; Shawver LM; Wessel AW; Luo Y; Pelletier M; Tsai WL; Lee Y; Vonortas S; Cheng L; Ashwell JD; Orange JS; Siegel RM; Hanson EP
Proc Natl Acad Sci U S A; 2016 Feb; 113(6):1612-7. PubMed ID: 26802121
[TBL] [Abstract][Full Text] [Related]
3. A20 overexpression inhibits lipopolysaccharide-induced NF-κB activation, TRAF6 and CD40 expression in rat peritoneal mesothelial cells.
Zou XL; Pei DA; Yan JZ; Xu G; Wu P
Int J Mol Sci; 2014 Apr; 15(4):6592-608. PubMed ID: 24747594
[TBL] [Abstract][Full Text] [Related]
4. Downstream activation of NF-κB in the EDA-A1/EDAR signalling in Sjögren's syndrome and its regulation by the ubiquitin-editing enzyme A20.
Sisto M; Barca A; Lofrumento DD; Lisi S
Clin Exp Immunol; 2016 May; 184(2):183-96. PubMed ID: 26724675
[TBL] [Abstract][Full Text] [Related]
5. A novel missense mutation in TNFAIP3 causes haploinsufficiency of A20.
Jiang W; Deng M; Gan C; Wang L; Mao H; Li Q
Cell Immunol; 2022 Jan; 371():104453. PubMed ID: 34808442
[TBL] [Abstract][Full Text] [Related]
6. ABIN-1 binds to NEMO/IKKgamma and co-operates with A20 in inhibiting NF-kappaB.
Mauro C; Pacifico F; Lavorgna A; Mellone S; Iannetti A; Acquaviva R; Formisano S; Vito P; Leonardi A
J Biol Chem; 2006 Jul; 281(27):18482-8. PubMed ID: 16684768
[TBL] [Abstract][Full Text] [Related]
7. Y14 positively regulates TNF-α-induced NF-κB transcriptional activity via interacting RIP1 and TRADD beyond an exon junction complex protein.
Togi S; Shiga K; Muromoto R; Kato M; Souma Y; Sekine Y; Kon S; Oritani K; Matsuda T
J Immunol; 2013 Aug; 191(3):1436-44. PubMed ID: 23817415
[TBL] [Abstract][Full Text] [Related]
8. Specific recognition of linear polyubiquitin by A20 zinc finger 7 is involved in NF-κB regulation.
Tokunaga F; Nishimasu H; Ishitani R; Goto E; Noguchi T; Mio K; Kamei K; Ma A; Iwai K; Nureki O
EMBO J; 2012 Oct; 31(19):3856-70. PubMed ID: 23032187
[TBL] [Abstract][Full Text] [Related]
9. Mutations in the genes coding for the NF-κB regulating factors IκBα and A20 are uncommon in nodular lymphocyte-predominant Hodgkin's lymphoma.
Schumacher MA; Schmitz R; Brune V; Tiacci E; Döring C; Hansmann ML; Siebert R; Küppers R
Haematologica; 2010 Jan; 95(1):153-7. PubMed ID: 19648161
[TBL] [Abstract][Full Text] [Related]
10. Molecular basis for the unique deubiquitinating activity of the NF-kappaB inhibitor A20.
Lin SC; Chung JY; Lamothe B; Rajashankar K; Lu M; Lo YC; Lam AY; Darnay BG; Wu H
J Mol Biol; 2008 Feb; 376(2):526-40. PubMed ID: 18164316
[TBL] [Abstract][Full Text] [Related]
11. Haploinsufficiency of A20 Due to Novel Mutations in TNFAIP3.
He T; Huang Y; Luo Y; Xia Y; Wang L; Zhang H; Ling J; Yang J
J Clin Immunol; 2020 Jul; 40(5):741-751. PubMed ID: 32514655
[TBL] [Abstract][Full Text] [Related]
12. DSIF restricts NF-κB signaling by coordinating elongation with mRNA processing of negative feedback genes.
Diamant G; Amir-Zilberstein L; Yamaguchi Y; Handa H; Dikstein R
Cell Rep; 2012 Oct; 2(4):722-31. PubMed ID: 23041311
[TBL] [Abstract][Full Text] [Related]
13. The RING ubiquitin E3 RNF114 interacts with A20 and modulates NF-κB activity and T-cell activation.
Rodriguez MS; Egaña I; Lopitz-Otsoa F; Aillet F; Lopez-Mato MP; Dorronsoro A; Lobato-Gil S; Sutherland JD; Barrio R; Trigueros C; Lang V
Cell Death Dis; 2014 Aug; 5(8):e1399. PubMed ID: 25165885
[TBL] [Abstract][Full Text] [Related]
14. A20 negatively regulates T cell receptor signaling to NF-kappaB by cleaving Malt1 ubiquitin chains.
Düwel M; Welteke V; Oeckinghaus A; Baens M; Kloo B; Ferch U; Darnay BG; Ruland J; Marynen P; Krappmann D
J Immunol; 2009 Jun; 182(12):7718-28. PubMed ID: 19494296
[TBL] [Abstract][Full Text] [Related]
15. An Update on Autoinflammatory Diseases: Relopathies.
Steiner A; Harapas CR; Masters SL; Davidson S
Curr Rheumatol Rep; 2018 May; 20(7):39. PubMed ID: 29846841
[TBL] [Abstract][Full Text] [Related]
16. Aberrant Low Expression of A20 in Tumor Necrosis Factor-α-stimulated SLE Monocytes Mediates Sustained NF-κB Inflammatory Response.
Shi X; Qian T; Li M; Chen F; Chen Y; Hao F
Immunol Invest; 2015; 44(5):497-508. PubMed ID: 26107748
[TBL] [Abstract][Full Text] [Related]
17. Proinflammatory mediators alter expression of nuclear factor kappa B-regulating deubiquitinases in sinonasal epithelial cells.
Li P; Wang Y; Turner JH
Int Forum Allergy Rhinol; 2015 Jul; 5(7):583-9. PubMed ID: 25907801
[TBL] [Abstract][Full Text] [Related]
18. The ubiquitin-editing enzyme A20 (TNFAIP3) is a central regulator of immunopathology.
Vereecke L; Beyaert R; van Loo G
Trends Immunol; 2009 Aug; 30(8):383-91. PubMed ID: 19643665
[TBL] [Abstract][Full Text] [Related]
19. NF-kappaB suppression by the deubiquitinating enzyme Cezanne: a novel negative feedback loop in pro-inflammatory signaling.
Enesa K; Zakkar M; Chaudhury H; Luong le A; Rawlinson L; Mason JC; Haskard DO; Dean JL; Evans PC
J Biol Chem; 2008 Mar; 283(11):7036-45. PubMed ID: 18178551
[TBL] [Abstract][Full Text] [Related]
20. miR-29 acts as a decoy in sarcomas to protect the tumor suppressor A20 mRNA from degradation by HuR.
Balkhi MY; Iwenofu OH; Bakkar N; Ladner KJ; Chandler DS; Houghton PJ; London CA; Kraybill W; Perrotti D; Croce CM; Keller C; Guttridge DC
Sci Signal; 2013 Jul; 6(286):ra63. PubMed ID: 23901138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
